Anixa Biosciences Announces Opening of Enrollment for Keytruda Arm in Ongoing Breast Cancer Vaccine Clinical Trial

SAN JOSE, Calif., Aug. 7, 2023. Anixa Biosciences, Inc. ( " Anixa " or the " Company " ), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has begun enrolling subjects in a...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials